Skip to content
  • News
  • Compare
  • Capital
variis
  • Clinics
  • Companies
  • Protocols
  • Specialists
  • Events
  • Funds
  • Press
variis

Longevity intelligence for Singapore and Australia. Sourced and evidence-graded.

Directories

  • Clinics
  • Companies
  • Protocols
  • Specialists
  • Funds
  • Events

Read

  • Archive
  • Capital
  • Compare
  • Glossary

Markets

  • Singapore
  • Australia

variis

  • About
  • Editorial standards
  • AI transparency
  • Corrections
  • Press

Legal

  • Medical disclaimer
  • Privacy policy
  • Terms of service

AI-assisted reporting, human-reviewed. Every claim sourced and graded. Not medical advice.

© 2026 variis · Singapore · Australia

  1. Home
  2. Articles

Archive

Every story variis has published.

The complete record of variis coverage across Singapore and Australia. Filter by market or topic. Sourced and evidence-graded.

Market
SingaporeAustraliaSingapore and AustraliaGlobal
Topic
ScienceRegulatoryClinicalCapitalPublic marketsIndustryProtocolLifestyleOpinion
Clear filters
MarketAll
AllSingaporeAustraliaSingapore and AustraliaGlobal
TopicScience
AllScienceRegulatoryClinicalCapitalPublic marketsIndustryProtocolLifestyleOpinion
Clear filters
Global · ProtocolGLP-1s and healthspan: a 2026 reader’s primer

Global · Protocol

GLP-1s and healthspan: a 2026 reader’s primer

Oral GLP-1s arrived in force in 2026. What the evidence supports , and what it does not.

Clinical6 min read1 Jul